CHENWI, COLLINS AMBE
CHENWI, COLLINS AMBE
Dipartimento di Medicina Sperimentale
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens
2023-01-01 Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study
2023-01-01 Togna Pabo, Wlr; Fokam, J; Njume, D; Takou, D; Santoro, M; Nyasa, Rb; Chenwi, C; Mpouel, Ml; Beloumou, G; Jagni, Esn; Nka, Ad; Ka'E, Ac; Teto, G; Dambaya, B; Djupsa, S; Gouissi Anguechia, Dh; Molimbou, E; Kamta, C; Bala, L; Lambo, V; Halle-Ekane, Eg; Colizzi, V; Perno, Cf; Ndjolo, A; Ndip Ndip, R
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
2023-01-01 Fokam, J; Chenwi, C; Takou, D; Santoro, M; Tala, V; Teto, G; Beloumou, G; Ngoufack Jagni Semengue, E; Dambaya, B; Djupsa, S; Kembou, E; Pamen Bouba, N; Ajeh, R; Cappelli, G; Mbanya, D; Colizzi, V; Ceccherini-Silberstein, F; Perno, C; Ndjolo, A
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
2023-01-01 Fokam, J; Chenwi, Ca; Tala, V; Takou, D; Mercedes Santoro, M; Teto, G; Dambaya, B; Anubodem, F; Ngoufack Jagni Semengue, E; Beloumou, G; Djupsa, S; Assomo, E; Fokunang, C; Alteri, C; Billong, S; Pamen Bouba, N; Ajeh, R; Colizzi, V; Mbanya, D; Ceccherini-Silberstein, F; Perno, C; Ndjolo, A
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2023 | HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens | Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F | Intervento a convegno | |
| 1-gen-2023 | HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study | Togna Pabo, Wlr; Fokam, J; Njume, D; Takou, D; Santoro, M; Nyasa, Rb; Chenwi, C; Mpouel, Ml; Beloumou, G; Jagni, Esn; Nka, Ad; Ka'E, Ac; Teto, G; Dambaya, B; Djupsa, S; Gouissi Anguechia, Dh; Molimbou, E; Kamta, C; Bala, L; Lambo, V; Halle-Ekane, Eg; Colizzi, V; Perno, Cf; Ndjolo, A; Ndip Ndip, R | Articolo su rivista | |
| 1-gen-2023 | Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens | Fokam, J; Chenwi, C; Takou, D; Santoro, M; Tala, V; Teto, G; Beloumou, G; Ngoufack Jagni Semengue, E; Dambaya, B; Djupsa, S; Kembou, E; Pamen Bouba, N; Ajeh, R; Cappelli, G; Mbanya, D; Colizzi, V; Ceccherini-Silberstein, F; Perno, C; Ndjolo, A | Articolo su rivista | |
| 1-gen-2023 | Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens | Fokam, J; Chenwi, Ca; Tala, V; Takou, D; Mercedes Santoro, M; Teto, G; Dambaya, B; Anubodem, F; Ngoufack Jagni Semengue, E; Beloumou, G; Djupsa, S; Assomo, E; Fokunang, C; Alteri, C; Billong, S; Pamen Bouba, N; Ajeh, R; Colizzi, V; Mbanya, D; Ceccherini-Silberstein, F; Perno, C; Ndjolo, A | Articolo su rivista |